Anat Naschitz

Tech continues to drive Israel’s economic resilience, but beneath the surface the ecosystem is showing signs of strain and health tech is feeling the pressure most. The announcement of clinical AI company Aidoc's recent $150 million raise, backed by General Catalyst, Square Peg, nVentures (NVIDIA’s venture capital arm), and four major U.S. health systems, is a sign of what is still possible: when the science is solid, the platform is ready, and the value is global, capital will follow. This is proven by the over 45 million patients currently benefitting from Aidoc's integration across more than 150 health systems. Aidoc’s success is an outlier today, but it should be the model. As the largest sector in Israeli innovation, with over 1,600 companies, health tech should be a source of strength. Instead, in the first half of 2025, it drew just $630 million in private funding — the lowest total in five years. Median deal sizes are shrinking, and time from seed to Series A has stretched to 54 months, pointing to deep structural challenges rather than a short-term slowdown. Capital is flowing elsewhere, toward sectors with faster cycles and clearer paths to scale. Cybersecurity raised $2.2 billion with a median round size of $25 million in H1 2025, while business software led all sectors with $3.2 billion. Health tech is struggling to compete for attention, investment, and talent. These trends are part of a broader shift. Israel’s global innovation position is narrowing, infrastructure hasn’t kept pace with the needs of deep tech, and overreliance on a few sectors is leaving others under-supported. Talent shortages and limited access to global markets are compounding the pressure. At Startup Nation Central, we are seeing this firsthand. Through our work with the 8400 The Health Network Health Network and across the ecosystem, the signals are clear. Health tech is underfunded and underprioritized at a time when its relevance has never been greater. Still, the fundamentals are here. Israel has a strong scientific foundation, a deep pool of entrepreneurial talent, a world-class healthcare system, and health professionals with a track record of innovation. Add to that a growing global demand for health solutions, and the potential is clear. With targeted investment, a renewed focus on translational research, and the right strategic partnerships, health tech can not only recover but take the lead as Aidoc has. The opportunity is real and so is the urgency to act on it. 

108

‏9‏ ‏תגובות‏

Israel can either buy the algorithms that will rewrite medicine or build them. We do better when we build. In my new op-ed in The Jerusalem Post, I outline how Israel can lead the AI‑bio convergence with world‑class talent, deep real‑world data, GMP scale, and pragmatic regulation. Full piece: https://lnkd.in/gH2efe5F The momentum is here: Biolojic Design, Ltd. is programming antibodies. Immunai is mapping the immune system at single‑cell resolution. Aidoc and Viz.ai are moving life‑saving decisions faster in hospitals. At Somite AI.ai, we're developing AI foundation models for human stem cells to drive novel cell therapies at scale. If we align policy with execution, capturing even five percent of this value chain adds a Mobileye‑scale contributor to GDP. Let’s lead! Teva Pharmaceuticals, Pluri #AI #Biotech #CellTherapy #Israel #Healthcare

71

‏6‏ ‏תגובות‏

🚀 Welcoming Insignito Solutions Ltd to the ICI Fund Portfolio! Excited to share our investment in Insignito, an Israeli startup pioneering the field of #drone #acoustics. Insignito's AI-powered technologies dramatically reduce drone noise, enable accurate long-range acoustic detection, and provide mission planning tools that optimize performance in real-world environments. What makes Insignito truly stand out is its founding team — Itay Nourian (CEO), Yarden Eilat (CTO), and Dor Ruf (VP R&D) — three longtime colleagues from the Israeli Air Force who bring deep technical expertise, operational excellence, and the trust that comes from years of working together in high-stakes environments. We believe Insignito has the potential to set the global standard for drone acoustics, opening new opportunities across commercial, defense, and urban applications. 👏 Grateful to back this visionary team and excited to see what’s ahead. 📩 Read more about Insignito in our latest newsletter: https://lnkd.in/dgM5u24d . Innovation • Community • Intelligence #DroneTechnology #AIInnovation #DeepTech #IsraeliStartups #VentureCapital #FutureOfFlight #AerospaceInnovation Timothy Jones Prof. Yaron Wolfsthal Aviv Nizri Ari Goldfarb

67

‏8‏ ‏תגובות‏

#Deeptech Venture Capital funds? The new Yozma #FoF by the Israel Innovation Authority is open for applications until November 4th, to support Israeli or foreign Venture Capital funds who have a dedicated Israeli focused Deeptech fund, led by experienced GPs. * Winners will recieve an investment of between $4m to $10m per fund. *Min size of targeted fund: $32M, Max IIA investment: 12.5% of the fund size. * All fund sizes are eligible, from early-stage to growth-stage investors. The deadline for submission of applications is November 4th, 2025 For more details: https://lnkd.in/d6_r6EQy

50

‏1‏ ‏תגובה‏

Across our Early and Growth stage aMoon funds, we’ve invested over $300M in Israeli and Israel-related companies over the last few years, backing exceptional entrepreneurs on their journeys. The tech-to-health Bio-Convergence industry in Israel keeps pushing the boundaries, accelerating cure and bringing companies to fundable milestones. We are proud to have added four new transformational Israeli companies to our portfolio over the past year: • Magentiq Eye Ltd.: Transforming colonoscopy with AI-powered precision, Magentiq Eye’s FDA-approved platform is setting a new standard for real-time, accurate endoscopy diagnostics with versatility across the GI space. Already commercially deployed in the US and Europe, and collaborating with strategic players, it’s offering the most accurate and comprehensive solution in the market. • Lutris Pharma: Lutris is tackling one of the most painful side effects of cancer therapies, dermal toxicity, with a topical gel that helps patients stay on treatment longer, making cancer treatment more tolerable and effective. Using an innovative, patient-centered solution, Lutris is already making an impact in oncology care. • MetaSight Diagnostics: Using a robust discovery platform, MetaSight is pioneering the development of accurate, affordable, and accessible disease diagnostics and monitoring through advanced blood testing, designed for high-volume screening. • Air Doctor: Improving access to outpatient care worldwide, with a global network of over 20,000 local physicians and specialists. Through the Air Doctor app, travelers can receive medical care 24/7, locally or remotely. Israel’s unique combination of deep tech talent, world-class academia, and government support via the Israel Innovation Authority, creates fertile ground for HealthTech breakthroughs. And we’re not just investing, we’re helping build the next generation of global leaders through strategic partnerships with Microsoft, Amazon Web Services (AWS), Roche, Medtronic, and more. Israeli innovation keeps pushing forward, and so do we - for Israel, and for the world. #AcceleratingCure Eleos Health | MDClone | Nectin Therapeutics | Theranica | Lin Health | CartiHeal | Connie Health | Biolojic Design, Ltd. | caVos Biotherapeutics| Ultima Genomics | KAHR-Medical Ltd. | Coltac Therapeutics | Ibex Medical Analytics Yair Schindel, MD, MBA | Tomer Berkovitz | Todd Sone | Moshe Mor | Yaron Daniely | Reut Shema | Roy Wiesner | Yael Gruenbaum-Cohen | Gaby Hirsch | Adam Kotzen | Tamir Maixner

100

‏4‏ ‏תגובות‏

Huge news for team Brevel! 🥳 We've been granted another significant investment from the Israel Innovation Authority – almost $500k. This grant will be dedicated to taking our upstream process to the next level. With a stable process in place, now we’ll use this support to push boundaries and further optimize every aspect, including: ✨ Improving quality ✨ Increasing protein content & concentration ✨ Enhancing growth rates ✨ Boosting energy efficiency ✨ Optimizing media composition ✨ Further reducing production costs By fine-tuning our illuminated fermentation technology, we’re making microalgae protein production even more scalable, sustainable, and accessible — moving closer to a food system that works better for everyone. 🌱💡 A huge thank you to the Israeli Innovation Authority for backing our vision, and to our incredible team, partners, and investors who make progress like this possible. 💚 #Microalgae #Alternativeprotein #Plantbased #Foodtech #Investment

190

‏28‏ ‏תגובות‏

When the parents of an 8-year-old boy reached out, researchers at Tel Aviv University responded with science. A team from the Gray Faculty of Medical & Health Sciences | הפקולטה למדעי הרפואה והבריאות ע"ש גריי, led by Prof. Moran Rubinstein and Prof. Karen B. Avraham, developed the first mouse model for an extremely rare and fatal genetic disease affecting just 40 people worldwide. This model now enables deeper understanding of the disease and offers a platform to test new drug and gene therapies, bringing real hope to patients and families: https://lnkd.in/erK4dd3A #rarediseases #geneticdiseases #genetherapy #geneinnovation #medtech #healthtech #healthinnovation #innovation

47

‏1‏ ‏תגובה‏